[HTML] nih.gov

[HTML][HTML] Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment

Y Qiu, P Liao, H Wang, J Chen, Y Hu, R Hu… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
A high recurrence rate of non-Hodgkin's lymphoma (NHL) following chimeric antigen
receptor T (CAR T) cell treatment remains a bottleneck, and immunosuppressive tumor …
被引用次数：6 相关文章

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment

Y Qiu, P Liao, H Wang, J Chen, Y Hu… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
A high recurrence rate of non-Hodgkin's lymphoma (NHL) following chimeric antigen
receptor T (CAR T) cell treatment remains a bottleneck, and immunosuppressive tumor …

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment

Y Qiu, P Liao, H Wang, J Chen, Y Hu, R Hu… - … Journal of Biological …, 2023 - europepmc.org
A high recurrence rate of non-Hodgkin's lymphoma (NHL) following chimeric antigen
receptor T (CAR T) cell treatment remains a bottleneck, and immunosuppressive tumor …
[HTML] ijbs.com

[HTML][HTML] Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment

Y Qiu, P Liao, H Wang, J Chen, Y Hu, R Hu… - International Journal of …, 2023 - ijbs.com
A high recurrence rate of non-Hodgkin's lymphoma (NHL) following chimeric antigen
receptor T (CAR T) cell treatment remains a bottleneck, and immunosuppressive tumor …

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment.

Y Qiu, P Liao, H Wang, J Chen, Y Hu, R Hu… - … Journal of Biological …, 2023 - europepmc.org
A high recurrence rate of non-Hodgkin's lymphoma (NHL) following chimeric antigen
receptor T (CAR T) cell treatment remains a bottleneck, and immunosuppressive tumor …
[PDF] ijbs.com

[PDF][PDF] Enhanced tumor immunotherapy by polyfunctional CD19-CART cells engineered to secrete anti-CD47 single-chain variable fragment

Y Qiu, P Liao, H Wang, J Chen, Y Hu, R Hu, H Zhang… - ijbs.com
A. DNA of T cells was extracted then amplified by PCR followed by DNA electrophoresis to
verify the expression of CAR fragments. B. QPCR was performed to validate CAR …